Loading company…
Scipher Medicine builds machine learning drug development and drug response prediction platforms from Massachusetts.
Based in Massachusetts, US, Scipher Medicine Corporation was founded in 2014 by Dr. Joe Loscalzo and Dr. Albert-Laszlo Barabasi. The company builds drug development platforms that use machine learning and AI on genetic data, including ScipherIx, ScipherDx and ScipherRx. Its PrismRA patient molecular signature test targets rheumatoid arthritis. In March 2021 it raised USD 82 million in Series C funding, co-led by new investor aMoon and returning investor Northpond Ventures.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in